Jasper Therapeutics votes to approve reverse stock split
The company amended its charter to combine 30 class shares into one effective November 6, avoiding delisting. It also increased authorized shares.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed